• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

情感性尿失禁对选择性5-羟色胺再摄取抑制剂的快速反应。

Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.

作者信息

Nahas Z, Arlinghaus K A, Kotrla K J, Clearman R R, George M S

机构信息

Medical University of South Carolina, Department of Psychiatry, Charleston, SC 29403, USA.

出版信息

J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):453-5. doi: 10.1176/jnp.10.4.453.

DOI:10.1176/jnp.10.4.453
PMID:9813792
Abstract

Emotional incontinence (EI) is a perturbing condition characterized by uncontrollable outbursts of exaggerated, involuntary facial expressions and pathological crying or laughter. There is increasing evidence that serotonergic neurotransmission may be damaged in EI. The authors report 4 pathological crying cases (3 poststroke and 1 with multiple sclerosis) and 1 case of pathological laughter after traumatic brain injury. EI improved dramatically with three different selective serotonin reuptake inhibitors (fluoxetine, sertraline, and paroxetine) in the context of these different CNS diseases.

摘要

情感失禁(EI)是一种令人困扰的病症,其特征为无法控制地爆发夸张、不自主的面部表情以及病理性哭笑。越来越多的证据表明,EI 中血清素能神经传递可能受损。作者报告了 4 例病理性哭泣病例(3 例中风后病例和 1 例多发性硬化症病例)以及 1 例创伤性脑损伤后的病理性大笑病例。在这些不同的中枢神经系统疾病背景下,三种不同的选择性 5-羟色胺再摄取抑制剂(氟西汀、舍曲林和帕罗西汀)使 EI 显著改善。

相似文献

1
Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.情感性尿失禁对选择性5-羟色胺再摄取抑制剂的快速反应。
J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):453-5. doi: 10.1176/jnp.10.4.453.
2
Emotional incontinence: a dramatic response to paroxetine.情感失禁:对帕罗西汀的显著反应。
Aust N Z J Med. 1996 Dec;26(6):844. doi: 10.1111/j.1445-5994.1996.tb00637.x.
3
Fluoxetine improves emotional incontinence.
Brain Inj. 1992 May-Jun;6(3):267-70. doi: 10.3109/02699059209029668.
4
Paroxetine versus citalopram treatment of pathological crying after brain injury.帕罗西汀与西酞普兰治疗脑损伤后病理性哭泣的对比研究
Brain Inj. 1999 Oct;13(10):805-11. doi: 10.1080/026990599121197.
5
Treatment of poststroke pathological crying.中风后病理性哭泣的治疗
Stroke. 1997 Nov;28(11):2321-2.
6
Emotional incontinence--the other poststroke phenomenon.
Med J Malaysia. 2006 Oct;61(4):490-2.
7
Are paroxetine, fluoxetine, and sertraline equally effective for depression?帕罗西汀、氟西汀和舍曲林治疗抑郁症的效果相同吗?
J Fam Pract. 2002 Mar;51(3):285.
8
Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine.笑到流泪:创伤性脑损伤患者的病理性哭笑及拉莫三嗪治疗
Epilepsy Behav. 2006 May;8(3):610-5. doi: 10.1016/j.yebeh.2006.01.017. Epub 2006 Feb 28.
9
Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine.一名患有创伤性脑损伤及随后出现以病理性哭笑为特征的情绪波动的高功能个体使用右美沙芬/奎尼丁的治疗方法。
Medicine (Baltimore). 2016 Mar;95(12):e2886. doi: 10.1097/MD.0000000000002886.
10
Response to Editorial Comments to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.对关于血浆褪黑素水平与选择性5-羟色胺再摄取抑制剂治疗早泄疗效之间关系的社论评论的回应
Int J Urol. 2014 Sep;21(9):921-2. doi: 10.1111/iju.12480. Epub 2014 May 13.

引用本文的文献

1
Pharmaceutical interventions for emotionalism after stroke.脑卒中后情感障碍的药物干预。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD003690. doi: 10.1002/14651858.CD003690.pub5.
2
Current and Potential Pharmacologic Therapies for Traumatic Brain Injury.创伤性脑损伤的现有及潜在药物治疗方法
Pharmaceuticals (Basel). 2022 Jul 6;15(7):838. doi: 10.3390/ph15070838.
3
Pharmaceutical interventions for emotionalism after stroke.中风后情感障碍的药物干预措施。
Cochrane Database Syst Rev. 2019 Mar 19;3(3):CD003690. doi: 10.1002/14651858.CD003690.pub4.
4
Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence.用于治疗创伤性脑损伤后神经认知和神经精神障碍的选择性5-羟色胺再摄取抑制剂:当前证据评估
Brain Sci. 2017 Jul 25;7(8):93. doi: 10.3390/brainsci7080093.
5
Pathological laughter as onset symptom in atypical parkinsonisms.病理性发笑作为非典型帕金森综合征的起始症状
J Neurol. 2017 Jan;264(1):182-184. doi: 10.1007/s00415-016-8351-5. Epub 2016 Nov 24.
6
Neuronal Dysregulation in Stroke-Associated Pseudobulbar Affect (PBA): Diagnostic Scales and Current Treatment Options.中风相关性假性球麻痹(PBA)中的神经元调节异常:诊断量表及当前治疗选择
J Neurol Neurophysiol. 2015 Oct;6(5). doi: 10.4172/2155-9562.1000323. Epub 2015 Oct 31.
7
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.评估右美沙芬/奎尼丁治疗假性延髓情感障碍的安全性和有效性。
Neuropsychiatr Dis Treat. 2014 Jun 26;10:1161-74. doi: 10.2147/NDT.S30713. eCollection 2014.
8
Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.15q 重复和 Angelman 综合征小鼠模型中血清素、多巴胺和去甲肾上腺素水平的改变。
PLoS One. 2012;7(8):e43030. doi: 10.1371/journal.pone.0043030. Epub 2012 Aug 16.
9
Current concepts in the pharmacotherapy of pseudobulbar affect.假性延髓情绪障碍的药物治疗的当前概念。
Drugs. 2011 Jun 18;71(9):1193-207. doi: 10.2165/11591450-000000000-00000.
10
[Amyotrophic lateral sclerosis: management of bulbar symptoms].[肌萎缩侧索硬化症:延髓症状的管理]
Nervenarzt. 2010 Oct;81(10):1218-25. doi: 10.1007/s00115-010-3008-6.